Dr. Alessio Fasano Joins Reckitt as Chief Science and Medical Officer

Dr. Alessio Fasano Appointed as Chief Science and Medical Officer at Reckitt

Reckitt, a prominent player in the consumer health market, has announced the highly anticipated appointment of Dr. Alessio Fasano as their new Chief Science and Medical Officer, specifically for the Mead Johnson Nutrition (MJN) division. In this pivotal role, Dr. Fasano will be charged with spearheading MJN's global science initiatives while advancing the innovation of key nutrition products such as Enfamil® and Nutramigen®.

Dr. Fasano steps into this role with an impressive background in pediatric nutrition. Previously affiliated with Mass General Brigham, he is recognized for his significant contributions to the fields of child healthcare and nutrition. With over 25 years of specialized experience, he is particularly renowned for his work on celiac disease, the gut microbiome, and various autoimmune conditions. His extensive research includes more than 450 peer-reviewed publications and over 160 patents.

As he takes charge of a well-established brand generating $3.2 billion, Dr. Fasano is expected to leverage his expertise to foster groundbreaking nutritional solutions that cater to consumers from infants to the elderly. His appointment emphasizes a commitment to scientific rigor and innovation at MJN, which has a proud legacy of science-based nutrition dating back almost 120 years.

Susan Sholtis, President of MJN, expressed enthusiasm regarding Dr. Fasano's onboarding, stating, "We are honored to have a medical scientist of Dr. Fasano’s caliber guiding our scientific endeavors and integrity." This sentiment is backed by significant expectations for new product development strategies that will solidify MJN's standing as a leader in nutrition.

Dr. Fasano's multifaceted career complements his role at Reckitt perfectly. He serves as the W. Allan Walker Chair of Pediatrics at Mass General Brigham, where he is deeply involved in pediatric gastroenterology and nutrition. His position also enables him to maintain crucial academic ties, enriching MJN with cutting-edge research and development opportunities. Dr. Fasano has stated his enthusiasm about contributing to a field that he believes has reached new heights of knowledge, particularly regarding the dietary needs of vulnerable populations.

Moreover, Dr. Fasano's commitment to blending academic insight with industrial application positions him as a vital bridge between these two worlds, enabling crucial partnerships that could lead to groundbreaking advancements in nutritional science. His vision to enhance nutrition for children and the elderly reflects shared views within the company about the importance of delivering quality and effective nutrition solutions.

Indeed, Reckitt recognizes the significance of rigorous scientific methodology as an essential driver for quality assurance. Dr. Fasano's new position allows for the integration of robust clinical evidence into innovative product development, ensuring that MJN continues to meet the nutritional needs of families worldwide.

Based at MJN's headquarters in Evansville, Indiana, Dr. Fasano will also retain his affiliations with the National Institutes of Health (NIH), where he serves as an ad hoc reviewer and chairs numerous study sections.

The selection of Dr. Alessio Fasano underscores Reckitt's unwavering commitment to protecting, healing, and nurturing across its extensive range of health and nutrition products. With his esteemed track record and profound knowledge, Dr. Fasano is poised to enhance the future of pediatric nutrition and beyond, ensuring that quality care remains accessible to every family.

For more information about Reckitt and their commitment to innovative healthcare solutions, visit Reckitt’s website.